Trending Now
Markets continue their upward march unabated
Markers continue their upward march unabated. Despite rising death tolls from the coronavirus, equity markets feel obliged to push to new highs....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Progenity Inc. (NASDAQ: PROG) Receives Single-Molecule Detection Platform Patent From USPTO
Progenity Inc. (NASDAQ: PROG) has announced a new patent associated with a single-molecule detection platform currently under development.
The patent covers single target nucleic acid...
MAKE IT MODERN
LATEST REVIEWS
MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2...
MediciNova Inc. (NASDAQ:MNOV) announced that its intranasal COVID-19 vaccine candidate that is employing the BC-PIV tech, induced systemic serum IgG as well as mucosal...
MAKE IT MODERN
PERFORMANCE TRAINING
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces That Janssen Biotech Has Received Approval For DARZALEK...
Halozyme Therapeutics Inc. (NASDAQ: HALO) has announced that the US FDA has granted Janssen Biotech Inc. approval for DARZALEK FASPRO in combination with kyprolis...
The Post-Pandemic Virus Bull Market is Coming (APT, ALST, LAKE)
The Wall Street Journal ran an interesting article earlier this week pointing out the growing consensus view that the Covid-19 pandemic crisis...
Inhibikase Therapeutics Inc. (NASDAQ: IKT) Publishes Study Showing Oral c-Abl Kinase Inhibitor’s Potential Ion...
Inhibikase Therapeutics Inc. (NASDAQ: IKT) has announced a publication detailing the biochemical rationale and possible benefits of Abelson Tyrosine kinase inhibition as a possible...
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence Platform to Investigate...
Aging is the biggest risk factor for developing a majority of chronic illnesses. However, scientific discoveries indicate that there are treatments that can prevent...
The Huge Opportunity in Diagnostic Testing Stocks (LH, GDBY, ABT, BIO, CVS, EPWCF, WBA)
Despite its tragic human toll, the pandemic accomplished a number of major societal leaps, including deregulating telehealth, penetrating delivery and virtual communications...
MAKE IT MODERN
